Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1993 Feb;67(2):765–772. doi: 10.1128/jvi.67.2.765-772.1993

B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.

J P Langeveld 1, J I Casal 1, C Vela 1, K Dalsgaard 1, S H Smale 1, W C Puijk 1, R H Meloen 1
PMCID: PMC237429  PMID: 7678305

Abstract

Ten antigenic sites on canine parvovirus (CPV) were mapped with a complete set of overlapping nonapeptides of the capsid proteins VP1 and VP2: five of these sites were recognized by sera from CPV-infected dogs, three were recognized by a rabbit anti-CPV antiserum, and two were recognized by murine monoclonal anti-CPV antibodies. A region covering the first 21 amino-terminal amino acid residues of VP2 was recognized by three sera from infected dogs, one neutralizing rabbit antiserum, and one neutralizing murine monoclonal antibody. Immunoabsorption experiments with full virions indicated that at least 6 of the 10 antigenic sites are located on the surface. Of these six, three sites occur in the amino terminus of VP2. When superimposed on the three-dimensional structure of canine parvovirus (J. Tsao, M. S. Chapman, M. Agbandje, W. Keller, K. Smith, H. Wu, M. Luo, T. J. Smith, M. G. Rossmann, R. W. Compans, and C. R. Parrish, Science 251:1456-1464, 1991), the other three epitopes are located on two loops of VP2 which form the highly exposed "spike" around the threefold-symmetry axis of the virus. Thus, these regions (amino terminus and loops 1 and 3) are of interest as major target sites for induction of neutralizing antibodies.

Full text

PDF
765

Images in this article

769Image
on p.769
770Image
on p.770

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appel M. J., Scott F. W., Carmichael L. E. Isolation and immunisation studies of a canine parco-like virus from dogs with haemorrhagic enteritis. Vet Rec. 1979 Aug 25;105(8):156–159. doi: 10.1136/vr.105.8.156. [DOI] [PubMed] [Google Scholar]
  2. Carmichael L. E., Joubert J. C., Pollock R. V. A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response. Cornell Vet. 1981 Oct;71(4):408–427. [PubMed] [Google Scholar]
  3. Carmichael L. E., Joubert J. C., Pollock R. V. A modified live canine parvovirus vaccine. II. Immune response. Cornell Vet. 1983 Jan;73(1):13–29. [PubMed] [Google Scholar]
  4. Carmichael L. E., Joubert J. C., Pollock R. V. Hemagglutination by canine parvovirus: serologic studies and diagnostic applications. Am J Vet Res. 1980 May;41(5):784–791. [PubMed] [Google Scholar]
  5. Chou P. Y., Fasman G. D. Prediction of beta-turns. Biophys J. 1979 Jun;26(3):367–383. doi: 10.1016/S0006-3495(79)85259-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chow M., Yabrov R., Bittle J., Hogle J., Baltimore D. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A. 1985 Feb;82(3):910–914. doi: 10.1073/pnas.82.3.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clinton G. M., Hayashi M. The parvovirus MVM: a comparison of heavy and light particle infectivity and their density conversion in vitro. Virology. 1976 Oct 1;74(1):57–63. doi: 10.1016/0042-6822(76)90127-6. [DOI] [PubMed] [Google Scholar]
  8. Cotmore S. F., Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res. 1987;33:91–174. doi: 10.1016/s0065-3527(08)60317-6. [DOI] [PubMed] [Google Scholar]
  9. Emini E. A., Jameson B. A., Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature. 1983 Aug 25;304(5928):699–703. doi: 10.1038/304699a0. [DOI] [PubMed] [Google Scholar]
  10. Eugster A. K. Studies on canine parvovirus infections: development of an inactivated vaccine. Am J Vet Res. 1980 Dec;41(12):2020–2024. [PubMed] [Google Scholar]
  11. Geysen H. M., Meloen R. H., Barteling S. J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A. 1984 Jul;81(13):3998–4002. doi: 10.1073/pnas.81.13.3998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. López de Turiso J. A., Cortés E., Martínez C., Ruiz de Ybáez R., Simarro I., Vela C., Casal I. Recombinant vaccine for canine parvovirus in dogs. J Virol. 1992 May;66(5):2748–2753. doi: 10.1128/jvi.66.5.2748-2753.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. López de Turiso J. A., Cortés E., Ranz A., García J., Sanz A., Vela C., Casal J. I. Fine mapping of canine parvovirus B cell epitopes. J Gen Virol. 1991 Oct;72(Pt 10):2445–2456. doi: 10.1099/0022-1317-72-10-2445. [DOI] [PubMed] [Google Scholar]
  14. Martyn J. C., Davidson B. E., Studdert M. J. Nucleotide sequence of feline panleukopenia virus: comparison with canine parvovirus identifies host-specific differences. J Gen Virol. 1990 Nov;71(Pt 11):2747–2753. doi: 10.1099/0022-1317-71-11-2747. [DOI] [PubMed] [Google Scholar]
  15. Meloen R. H., Amerongen A. V., Hage-Van Noort M., Langedijk J. P., Posthumus W. P., Puyk W. C., Plasman H., Lenstra J. A., Langeveld J. P. The use of peptides to reconstruct conformational determinants; a brief review. Ann Biol Clin (Paris) 1991;49(4):231–241. [PubMed] [Google Scholar]
  16. Meunier P. C., Cooper B. J., Appel M. J., Lanieu M. E., Slauson D. O. Pathogenesis of canine parvovirus enteritis: sequential virus distribution and passive immunization studies. Vet Pathol. 1985 Nov;22(6):617–624. doi: 10.1177/030098588502200617. [DOI] [PubMed] [Google Scholar]
  17. Paradiso P. R. Infectious process of the parvovirus H-1: correlation of protein content, particle density, and viral infectivity. J Virol. 1981 Sep;39(3):800–807. doi: 10.1128/jvi.39.3.800-807.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Paradiso P. R., Rhode S. L., 3rd, Singer I. I. Canine parvovirus: a biochemical and ultrastructural characterization. J Gen Virol. 1982 Sep;62(Pt 1):113–125. doi: 10.1099/0022-1317-62-1-113. [DOI] [PubMed] [Google Scholar]
  19. Paradiso P. R., Williams K. R., Costantino R. L. Mapping of the amino terminus of the H-1 parvovirus major capsid protein. J Virol. 1984 Oct;52(1):77–81. doi: 10.1128/jvi.52.1.77-81.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Parrish C. R., Aquadro C. F., Carmichael L. E. Canine host range and a specific epitope map along with variant sequences in the capsid protein gene of canine parvovirus and related feline, mink, and raccoon parvoviruses. Virology. 1988 Oct;166(2):293–307. doi: 10.1016/0042-6822(88)90500-4. [DOI] [PubMed] [Google Scholar]
  21. Parrish C. R., Carmichael L. E., Antczak D. F. Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch Virol. 1982;72(4):267–278. doi: 10.1007/BF01315223. [DOI] [PubMed] [Google Scholar]
  22. Parrish C. R., Carmichael L. E. Antigenic structure and variation of canine parvovirus type-2, feline panleukopenia virus, and mink enteritis virus. Virology. 1983 Sep;129(2):401–414. doi: 10.1016/0042-6822(83)90179-4. [DOI] [PubMed] [Google Scholar]
  23. Parrish C. R., Carmichael L. E. Characterization and recombination mapping of an antigenic and host range mutation of canine parvovirus. Virology. 1986 Jan 15;148(1):121–132. doi: 10.1016/0042-6822(86)90408-3. [DOI] [PubMed] [Google Scholar]
  24. Parrish C. R. Emergence, natural history, and variation of canine, mink, and feline parvoviruses. Adv Virus Res. 1990;38:403–450. doi: 10.1016/S0065-3527(08)60867-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parrish C. R. Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virology. 1991 Jul;183(1):195–205. doi: 10.1016/0042-6822(91)90132-u. [DOI] [PubMed] [Google Scholar]
  26. Pollock R. V., Carmichael L. E. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines. Cornell Vet. 1982 Jan;72(1):16–35. [PubMed] [Google Scholar]
  27. Pollock R. V., Carmichael L. E. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc. 1982 Jan 1;180(1):37–42. [PubMed] [Google Scholar]
  28. Reed A. P., Jones E. V., Miller T. J. Nucleotide sequence and genome organization of canine parvovirus. J Virol. 1988 Jan;62(1):266–276. doi: 10.1128/jvi.62.1.266-276.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rhode S. L., 3rd Nucleotide sequence of the coat protein gene of canine parvovirus. J Virol. 1985 May;54(2):630–633. doi: 10.1128/jvi.54.2.630-633.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rimmelzwaan G. F., Carlson J., UytdeHaag F. G., Osterhaus A. D. A synthetic peptide derived from the amino acid sequence of canine parvovirus structural proteins which defines a B cell epitope and elicits antiviral antibody in BALB c mice. J Gen Virol. 1990 Nov;71(Pt 11):2741–2745. doi: 10.1099/0022-1317-71-11-2741. [DOI] [PubMed] [Google Scholar]
  31. Rossmann M. G., Arnold E., Erickson J. W., Frankenberger E. A., Griffith J. P., Hecht H. J., Johnson J. E., Kamer G., Luo M., Mosser A. G. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985 Sep 12;317(6033):145–153. doi: 10.1038/317145a0. [DOI] [PubMed] [Google Scholar]
  32. Rossmann M. G., Palmenberg A. C. Conservation of the putative receptor attachment site in picornaviruses. Virology. 1988 Jun;164(2):373–382. doi: 10.1016/0042-6822(88)90550-8. [DOI] [PubMed] [Google Scholar]
  33. Saliki J. T., Mizak B., Flore H. P., Gettig R. R., Burand J. P., Carmichael L. E., Wood H. A., Parrish C. R. Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol. 1992 Feb;73(Pt 2):369–374. doi: 10.1099/0022-1317-73-2-369. [DOI] [PubMed] [Google Scholar]
  34. Sherry B., Mosser A. G., Colonno R. J., Rueckert R. R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol. 1986 Jan;57(1):246–257. doi: 10.1128/jvi.57.1.246-257.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sherry B., Rueckert R. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol. 1985 Jan;53(1):137–143. doi: 10.1128/jvi.53.1.137-143.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Siegl G., Bates R. C., Berns K. I., Carter B. J., Kelly D. C., Kurstak E., Tattersall P. Characteristics and taxonomy of Parvoviridae. Intervirology. 1985;23(2):61–73. doi: 10.1159/000149587. [DOI] [PubMed] [Google Scholar]
  37. Tattersall P., Shatkin A. J., Ward D. C. Sequence homology between the structural polypeptides of minute virus of mice. J Mol Biol. 1977 Apr 25;111(4):375–394. doi: 10.1016/s0022-2836(77)80060-0. [DOI] [PubMed] [Google Scholar]
  38. Tratschin J. D., McMaster G. K., Kronauer G., Siegl G. Canine parvovirus: relationship to wild-type and vaccine strains of feline panleukopenia virus and mink enteritis virus. J Gen Virol. 1982 Jul;61(Pt 50):33–41. doi: 10.1099/0022-1317-61-1-33. [DOI] [PubMed] [Google Scholar]
  39. Tsao J., Chapman M. S., Agbandje M., Keller W., Smith K., Wu H., Luo M., Smith T. J., Rossmann M. G., Compans R. W. The three-dimensional structure of canine parvovirus and its functional implications. Science. 1991 Mar 22;251(5000):1456–1464. doi: 10.1126/science.2006420. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES